Corrigendum: a novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction.
Saved in:
| Title: | Corrigendum: a novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction. |
|---|---|
| Authors: | Chou C; Department of Medicine, Tufts University School of Medicine, Boston, MA, United States., Martin GL; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States., Perera G; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States., Awata J; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States., Larson A; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States., Blanton R; Department of Medicine, Tufts University School of Medicine, Boston, MA, United States.; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States., Chin MT; Department of Medicine, Tufts University School of Medicine, Boston, MA, United States.; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA, United States. |
| Source: | Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2024 Aug 16; Vol. 11, pp. 1455263. Date of Electronic Publication: 2024 Aug 16 (Print Publication: 2024). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
